Try our Advanced Search for more refined results
Texas
-
January 15, 2026
Musk Child's Mom Says Grok Created Nonconsensual Images
Influencer Ashley St. Clair, the mother of one of Elon Musk's children, has sued Musk's artificial intelligence company xAI, claiming she was depicted in sexually explicit imagery generated by Grok without her consent and that xAI has "chosen to willfully turn a blind eye and even celebrate" similar sexual exploitation.
-
January 15, 2026
Xreal Accuses Smart Glasses Rival Of Patent Infringement
Chinese-owned smart glasses maker Xreal on Thursday filed a lawsuit in Texas federal court against rival Viture Inc., accusing it of being a latecomer to the market and choosing a "shortcut" of patent infringement with its competing products.
-
January 15, 2026
Wrong Word Dooms Med Mal Suit Against UT Cancer Center
A Texas appeals court on Thursday dismissed a suit accusing the University of Texas M.D. Anderson Cancer Center of causing a cancer patient's injuries from "chemotherapy," saying that because the treatment was actually "immunotherapy," an exception to governmental immunity did not apply.
-
January 15, 2026
Energy Trader Says $5.5M Award Against Power Co. Is Valid
A British Virgin Islands energy trading and logistics company has asked a Texas federal court to throw out a Guatemalan power plant operator's bid to vacate a $5.5 million arbitral award, saying the operator has never disputed that its debt is outstanding.
-
January 15, 2026
Judge Sinks Claims Against Samsung In Converter IP Case
A Texas federal judge has agreed to throw out CogniPower LLC's accusations that certain Samsung products infringed power converter patents, accepting a magistrate judge's finding that a key infringement question has already been answered in another case.
-
January 15, 2026
5th Circ. Revives Allstate's Fraud Suit Over Car Crash Billing
The Fifth Circuit on Wednesday revived Allstate's racketeering suit alleging doctors and personal injury lawyers unleashed a barrage of unnecessary treatments for car accident patients and caused Allstate to pay $4.7 million in claims, finding the insurer sufficiently pled details about the conspiracy and specifics surrounding each allegedly fake medical billing.
-
January 15, 2026
Cal-Maine Gives Free Eggs To Settle Texas Price Gouging Suit
Cal-Maine Foods Inc. agreed to fork over 2 million free eggs to the state of Texas to settle claims of illegal price gouging, ending a suit brought by the state alleging Cal-Maine tripled the price of its eggs during the onset of the COVID-19 pandemic.
-
January 15, 2026
PTAB Denials, Reexams & New Patent Suits Rose In 2025
The volume of Patent Trial and Appeal Board petitions dropped last year, while requests for ex parte reexaminations surged with a 66% increase from those in 2024, according to a new report from Unified Patents.
-
January 15, 2026
BOE Owes $66.9M In Display Patent Case, Jury Says
A jury in the Eastern District of Texas on Thursday found that Chinese display maker BOE Technology Group Co. owes nearly $67 million for infringing a trio of LCD patents owned by an Irish company.
-
January 15, 2026
CVS Ducks Antitrust But Not Biz Interference Claim At 5th Circ.
A Fifth Circuit panel has largely sided with CVS Pharmacy and its Caremark affiliate by preserving a district court's dismissal of federal antitrust claims over a Mississippi pharmacy's rejection from participating in the pharmacy benefit manager's network, although the judges did revive state law claims.
-
January 15, 2026
Fed. Circ. Won't Stop Injunction Against BMW Foe In IP Fight
The Federal Circuit has declined for now to halt a Texas federal court's order blocking a patent company from pursuing legal action against BMW in Germany.
-
January 15, 2026
Texas Justices Seem Open To Nixing Roofer's $4M Verdict
The Texas Supreme Court seemed skeptical of a worker's claim that evidence of his consumption of a beer and half a joint six hours before he fell off a roof should not have gone before a jury, hinting Thursday that the contractor being sued may win its bid for a new trial.
-
January 15, 2026
5th Circ. Rejects Challenge To Texas LNG Construction Delay
The Fifth Circuit greenlighted work on a liquefied natural gas terminal in the Port of Brownsville, Texas, saying state regulators followed the correct rule when granting a third construction deadline extension for the project.
-
January 15, 2026
McGuireWoods Adds K&L Gates Energy Pro In Houston
McGuireWoods LLP has boosted its offerings to clients navigating infrastructure challenges related to the artificial intelligence boom and demand for data centers with a former K&L Gates partner in Houston who brings more than a decade of experience representing energy, infrastructure and data center developers, investors and lenders.
-
January 15, 2026
Sens. Advance Indiana Judge Nominee Grilled Over Sermons
A federal judicial nominee for Indiana who came under scrutiny by a Republican senator for his past sermons as an ordained elder was voted out of committee Thursday alongside five other judicial nominees.
-
January 15, 2026
FBFK Law Hires Former Clinton, Whitewater Investigator
FBFK Law has hired the former chair of Taylor Duma LLP's white collar defense practice who, in his more than four decade legal career, served as deputy independent counsel in the Whitewater-Lewinsky investigation, where he assisted with the grand jury proceedings involving former President Bill Clinton.
-
January 14, 2026
Full 5th Circ. Will Revisit PWFA's Constitutionality
The Fifth Circuit late Wednesday vacated a split panel opinion allowing enforcement of the Pregnant Workers Fairness Act against the state of Texas, granting an en banc rehearing to consider whether the U.S. Constitution required House lawmakers' physical presence to have a quorum when the statute was approved.
-
January 14, 2026
Pharmacy Wields Antitrust Law In Challenge To GLP-1 Giants
Eli Lilly & Co. and Novo Nordisk are using their dominant positions in the market for weight loss and diabetes medications to squash potential competitors, including through unlawful exclusivity agreements with telehealth providers, a compounding pharmacy alleged Wednesday in what it calls a landmark antitrust lawsuit.
-
January 14, 2026
Tort Report: Los Angeles Tops Annual 'Judicial Hellhole' List
Los Angeles' designation by a tort reform group as a top "judicial hellhole," and the latest in a suit over a Kentucky judge shot to death in his own chambers lead Law360's Tort Report, which compiles recent personal injury and medical malpractice news that may have flown under the radar.
-
January 14, 2026
BOE Settles Display Patent Suits As Other Remains At Trial
Chinese display maker BOE Technology Group Co. has settled two Eastern District of Texas patent suits brought by Optronic Sciences LLC, one of which was set for trial next month, according to a notice the parties filed, while an unrelated BOE patent trial is ongoing in the same court.
-
January 14, 2026
Texas Justices Seem Open To Judicial Review Of Hemp Rule
The Texas Supreme Court seemed skeptical of the Texas Department of State Health Services' argument that the judiciary lacks authority to review a decision to make delta-8 THC a controlled substance, asking Wednesday why the court should not have authority to enforce an existing law.
-
January 14, 2026
Alito Denies Bid To Avoid Depos In Texas Hair Bias Suit
U.S. Supreme Court Justice Samuel Alito on Wednesday shot down a bid from a Texas school district seeking to stave off depositions of two district officials in a case alleging the district discriminated against Black students who wore their hair in locs.
-
January 14, 2026
'The Work Has Changed': How White-Collar Attys Are Coping
The Trump administration's dramatic policy enforcement changes over the past year, along with turmoil and turnover at the U.S. Department of Justice, has tilted the white-collar world on its axis, forcing lawyers and firms to abruptly shift focus and expand their practices, sometimes beyond traditional white-collar criminal defense matters.
-
January 14, 2026
Vizient Beats Spurned Medical Tape Supplier At 5th Circ.
A Fifth Circuit panel refused to revive an antitrust suit accusing medical supplies group purchasing giant Vizient of locking in hospital customers, agreeing with a district court that a spurned would-be supplier failed at the threshold question of showing a market in which Vizient could be dominant.
-
January 14, 2026
Wholesaler Admits To $2.5M Opioid Diversion Scheme
A Miami-based pharmaceutical wholesaler has signed on to a two-year deferred prosecution agreement with federal prosecutors over a charge that it knowingly diverted opioids to "pill mill" pharmacies, bringing in more than $2.5 million.
Expert Analysis
-
Algorithmic Bias Risks Remain For Employers After AI Order
A recent executive order articulates a federal preference for a minimally burdensome approach to artificial intelligence regulation, but it doesn't eliminate employers' central compliance challenge or exposure when using AI tools, say Marjorie Soto Garcia and Joseph Mulherin at McDermott, and Candice Rosevear at Peregrine Economics.
-
Series
Fly-Fishing Makes Me A Better Lawyer
Much like skilled attorneys, the best anglers prize preparation, presentation and patience while respecting their adversaries — both human and trout, says Rob Braverman at Braverman Greenspun.
-
4 Ways GCs Can Manage Growing Service Of Process Volume
As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.
-
Series
The Law Firm Merger Diaries: Forming Measurable Ties
Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.
-
AG Watch: Va. Insulin Price Probe Signals Rising Scrutiny
Virginia Attorney General Jason Miyares' recent investigation into insulin manufacturers and pharmacy benefit managers for allegedly colluding to artificially inflate insulin prices reflects a broader trend to leverage consumer protection authority in high-impact healthcare matters, and the upcoming leadership change is unlikely to diminish scrutiny in this area, says Chuck Slemp at Cozen O'Connor.
-
Wrangling Over 'Good Faith' In Texas Commodity Contracts
As winter storm season brings fluctuating natural gas prices and ensuing price disputes, parties to gas and other commodity contracts face a question with few answers in Texas case law: how much buyers or sellers can reduce contractual requirements or outputs on a good faith basis, say attorneys at Jackson Walker.
-
A Look At EEOC Actions In 2025 And What's Next
President Donald Trump issued several executive orders last year that reshaped policy at the U.S. Equal Employment Opportunity Commission, and with the administration now controlling a majority of the commission, the EEOC may align itself fully with orders addressing disparate impact and transgender issues, say attorneys at Jones Day.
-
5 E-Discovery Predictions For 2026 And Beyond
2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.
-
How Developers Can Harness New Texas Zoning Framework
A Texas law introducing a new zoning framework has the potential to unlock meaningful multifamily development opportunities, but developers and their project teams should follow four steps to help identify how affected cities are interpreting and implementing the new law, says Angela Hunt at Munsch Hardt.
-
Where States Jumped In When SEC Stepped Back In 2025
The state regulators that picked up the slack when the U.S. Securities and Exchange Commission scaled back enforcement last year should not be underestimated as they continue to aggressively police areas where the SEC has lost interest and probe industries where SEC leadership has actively declined to intervene, say attorneys at Morgan Lewis.
-
2026 Enforcement Trends To Expect In Maritime And Int'l Trade
The maritime and international trade community should expect U.S. federal enforcement to ramp up in 2026, particularly via Office of Foreign Asset Control shipping sanctions, accelerating interagency investigations of trade fraud, and U.S. Coast Guard narcotics and pollution inspections, say attorneys at Holland & Knight.
-
2026 State AI Bills That Could Expand Liability, Insurance Risk
State bills legislating artificial intelligence that are expected to pass in 2026 will reshape the liability landscape for all companies incorporating AI solutions into their business operations, as any novel private rights of action authorized under AI-related statutes signal expanding exposures, say attorneys at Wiley.
-
Business Considerations Amid Hemp Product Policy Change
With the passage of a bill fundamentally narrowing the federal definition of "hemp," there are practical and business considerations that brands, manufacturers and other parties should heed over the next year, including operational strategies, evaluating contract and counterparty risk, and tax implications, say attorneys at Foley Hoag.
-
Series
Judges On AI: How Courts Can Boost Access To Justice
Arizona Court of Appeals Judge Samuel A. Thumma writes that generative artificial intelligence tools offer a profound opportunity to enhance access to justice and engender public confidence in courts’ use of technology, and judges can seize this opportunity in five key ways.
-
Opinion
The Case For Emulating, Not Dividing, The Ninth Circuit
Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.